Share
 
Title
Accelerating investigation of novel therapeutics in pregnancy: from theory to action
Code
SA024
Session Type
Satellite
Format
Hybrid
ROOM/CHANNEL
Room 516/Channel 6
Date Time
29 July 14:45 - 16:15
Moderators
Imelda Chipo MAHAKA, Pangaea Zimbabwe AIDS Trust, Zimbabwe
Saye KHOO, University of Liverpool, United Kingdom
Carmen PÉREZ CASAS, Unitaid, Switzerland
Organizer
The World Health Organization (WHO); Unitaid; The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network

The aim of the Satellite is to launch the JIAS supplement on Approaches to enhance and accelerate investigation of new HIV drugs in pregnancy, discuss the strategic actions required and explore the application of this work to HIV related co-infections. The Satellite will be a combination of engaging panels with a diverse range of key stakeholders that will 1) focus on actions to effectively implement the proposed framework, 2) highlight the voices of community members who will discuss the effective and meaningful support of participants in research and 3) explore application of the proposed framework to other disease areas (STIs, viral hepatitis, malaria and TB).

14:45
10 min
 Official launch of JIAS Supplement and overview of the framework to enhance and accelerate the study of new HIV drugs in pregnancy
Annette SOHN, amfAR, the Foundation for AIDS Research, Thailand
Martina PENAZZATO, WHO HQ, Switzerland
Elaine ABRAMS, IMPAACT Network & ICAP at Columbia University, United States
14:55
25 min
 Panel 1: Keeping momentum and generating tangible progress in accelerating research in pregnancy
Sinead DELANY-MORETLWE, University of the Witwatersrand, South Africa
Nahida CHAKHTOURA, The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), United States
Annemiek DE RUITER, ViiV Healthcare, United Kingdom
Saye KHOO, University of Liverpool, United Kingdom
Carmen PÉREZ CASAS, Unitaid, Switzerland
Leyla SAHIN, U.S. Food and Drug Administration (FDA), United States
15:20
25 min
 Effective and meaningful support of participants in research
Imelda Chipo MAHAKA, Pangaea Zimbabwe AIDS Trust, Zimbabwe
Mercy SHIBEMBA, Penta Foundation, United Kingdom
15:45
25 min
 Panel 2: Amplifying impact by joining forces across disease areas to study new drugs during pregnancy
Amita GUPTA, Johns Hopkins Bloomberg School of Public Health, United States
Carmen PÉREZ CASAS, Unitaid, Switzerland
Myriam EL-GAALOUL, Medicines for Malaria Venture, Switzerland
Manal EL-SAYED, Ain Shams University, Egypt
Melanie TAYLOR, Centers for Disease Control and Prevention, United States
16:10
5 min
 Bringing it all together: charting the path towards more equitable access to novel therapeutics
Meg DOHERTY, World Health Organization, Switzerland
Sharon NACHMAN, IMPAACT Network & Stony Brook University Hospital, United States